Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3)

The purpose of this grant is to provide funding, resources, and expertise to accelerate the development of diverse biotherapeutic modalities — including but not limited to antibodies, peptides, proteins, oligonucleotides, gene therapies, cell therapies, and other emerging therapeutic modalities — for the treatment of nervous and neuromuscular system disorders.

Funding: no fixed limit 

Duration: 5 years total 

Research Authority due date: 10 days prior to submission 

LIO (encouraged) due dates: 2712.24, 15.6.25, 15.12.25, 15.6.26, 15.12.26, 15.6.27

Full proposal due dates: 27.1.25, 15.7.25, 15.1.26, 15.7.26, 15.1.27. 15.7.27